Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
10 Novembre 2022 - 5:52PM
Biofrontera Inc. (Nasdaq:
BFRI), a biopharmaceutical company specializing in the
commercialization of dermatological products, announces it will
report financial results for the three and nine months ended
September 30, 2022 before the opening of the U.S. financial markets
on Monday, November 14, 2022. The Company will hold a conference
call that same day beginning at 11:00 a.m. Eastern time to discuss
those results, provide a business update and answer questions.
Conference Call and Webcast
Information
|
Event: |
Biofrontera Inc. Third Quarter 2022 Financial Results and Business
Update Conference Call |
|
Date: |
Monday, November 14, 2022 |
|
Time: |
11:00 a.m. Eastern time |
|
Conference call: |
1-877-877-1275 (U.S.)1-412-858-5202 (international) |
|
Webcast: |
Live and 90-day replay webcast are available here and at
www.investors.biofrontera-us.com. |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on photodynamic therapy (PDT) and topical
antibiotics. The Company’s licensed products are used for the
treatment of actinic keratoses, which are pre-cancerous skin
lesions, as well as impetigo, a bacterial skin infection. For more
information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
# # #
Grafico Azioni Biofrontera (NASDAQ:BFRIW)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Biofrontera (NASDAQ:BFRIW)
Storico
Da Feb 2024 a Feb 2025
